FindTrial
Sign In

A randomized trial comparing Franseen versus Trident needles with wet suction for EUS-guided fine-needle biopsy

A randomized trial comparing Franseen versus Trident needles with wet suction for EUS-guided fine-needle biopsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121318
Enrollment
Unknown
Registered
2026-03-30
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid space-occupying lesion of the pancreas

Interventions

Group A:Franseen needles were used during the EUS-FNB procedure
Group B:Trident needles were used during the EUS-FNB procedure

Sponsors

The Third People Hospital of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. lmaging findings suggestive of pancreatic solid sspace-occupying lesions (> 1 cm) andscheduled to undergo EUS-FNB (22G) (Endoscopic Ultrasound-Guided Fine Needle Biopsy); 3. Provided signedinformed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation; 2. History of hemorrhagic disorders or uncorrectable coagulation dysfunction. 3. Cardiopulmonary dysfunction.

Design outcomes

Primary

MeasureTime frame
Tissue adequacy;—

Secondary

MeasureTime frame
Sensitivity;Specificity;Positive Predictive Value (PPV);Negative Predictive Value (NPV);Accuracy;—

Countries

China

Contacts

Public ContactShan Jing

The Third People Hospital of Chengdu

tulip-sj@163.com+86 156 5885 0832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026